These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 10334382

  • 1. Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodies.
    Viscomi GC, Antonelli G, Bruno C, Scapol L, Malavasi F, Funaro A, Simeoni E, Pestka S, De Pisa F, Dianzani F.
    J Interferon Cytokine Res; 1999 Apr; 19(4):319-26. PubMed ID: 10334382
    [Abstract] [Full Text] [Related]

  • 2. Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha 4a--subtype reactivity, neutralisation of biological activities and epitope analysis.
    Overall ML, Hertzog PJ.
    Mol Immunol; 1992 Mar; 29(3):391-9. PubMed ID: 1372957
    [Abstract] [Full Text] [Related]

  • 3. Porcine leukocyte interferon exhibits close antigenic relatedness to human interferon alpha 2, but not to human interferon alpha 1.
    Karayianni-Vasconcelos G, Borecký L, Kontsek P.
    Vet Immunol Immunopathol; 1993 Oct; 38(3-4):359-65. PubMed ID: 7507275
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha.
    Exley T, Parti S, Barwick S, Meager A.
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2277-80. PubMed ID: 6512507
    [Abstract] [Full Text] [Related]

  • 5. Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35.
    Kontsek P, Borecký L, Novák M, Kontseková E, Máciková I, Krchnák V.
    J Interferon Res; 1991 Dec; 11(6):327-32. PubMed ID: 1724779
    [Abstract] [Full Text] [Related]

  • 6. Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.
    Cebrián M, Yagüe E, de Landázuri MO, Rodíguez-Moya M, Fresno M, Pezzi N, Llamazares S, Sánchez-Madrid F.
    J Immunol; 1987 Jan 15; 138(2):484-90. PubMed ID: 2432126
    [Abstract] [Full Text] [Related]

  • 7. Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons.
    Adolf GR.
    J Gen Virol; 1987 Jun 15; 68 ( Pt 6)():1669-76. PubMed ID: 2438379
    [Abstract] [Full Text] [Related]

  • 8. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
    Redlich PN, Grossberg SE.
    J Immunol; 1989 Sep 15; 143(6):1887-93. PubMed ID: 2476486
    [Abstract] [Full Text] [Related]

  • 9. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules.
    Schmeisser H, Hu R, Kontsek P, Bekisz J, Zoon K.
    J Interferon Cytokine Res; 2002 Apr 15; 22(4):463-72. PubMed ID: 12034029
    [Abstract] [Full Text] [Related]

  • 10. Production and characterization of four monoclonal antibodies specific for human interferon-alpha-1 and -alpha-2.
    Noll F, Handschack W, Eichmann E, Gaestel M, Schneider F, Kuhl R, Löster K.
    Biomed Biochim Acta; 1989 Apr 15; 48(1):165-76. PubMed ID: 2775248
    [Abstract] [Full Text] [Related]

  • 11. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
    Ross C, Svenson M, Hansen MB, Vejlsgaard GL, Bendtzen K.
    J Clin Invest; 1995 May 15; 95(5):1974-8. PubMed ID: 7738163
    [Abstract] [Full Text] [Related]

  • 12. Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-alpha subtypes.
    Brand CM, Leadbeater L, Bellati G, Marotta F, Ideo G.
    J Interferon Res; 1993 Apr 15; 13(2):121-5. PubMed ID: 7685368
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies to equine interferon-alpha (IFN-alpha): new tools to neutralize IFN-activity and to detect secreted IFN-alpha.
    Wagner B, Hillegas JM, Flaminio MJ, Wattrang E.
    Vet Immunol Immunopathol; 2008 Oct 15; 125(3-4):315-25. PubMed ID: 18586327
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibodies and enzyme immunoassays specific for human interferon (IFN) omega 1: evidence that IFN-omega 1 is a component of human leukocyte IFN.
    Adolf GR.
    Virology; 1990 Apr 15; 175(2):410-7. PubMed ID: 1691561
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibody to human beta interferon: characterization and application.
    Sugi M, Kato H, Fujimoto M, Utsumi J, Hosoi K, Shimizu H, Kobayashi S.
    Hybridoma; 1987 Jun 15; 6(3):313-20. PubMed ID: 3596615
    [Abstract] [Full Text] [Related]

  • 16. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.
    Antonelli G, Currenti M, Turriziani O, Dianzani F.
    J Infect Dis; 1991 Apr 15; 163(4):882-5. PubMed ID: 1901335
    [Abstract] [Full Text] [Related]

  • 17. A scFv antibody fragment as a therapeutic candidate to neutralize a broad diversity of human IFN-alpha subtypes.
    Depetris M, Casalis P, Kratje R, Etcheverrigaray M, Oggero M.
    J Immunol Methods; 2008 May 20; 334(1-2):104-13. PubMed ID: 18394641
    [Abstract] [Full Text] [Related]

  • 18. Are the acid-labile interferon alpha and interferon omega-1 identical?
    Kontsek P, Borecký L, Novák M.
    Virology; 1991 Mar 20; 181(1):416-8. PubMed ID: 1994590
    [Abstract] [Full Text] [Related]

  • 19. Three separate epitopes on human IFN-alpha variants defined by monoclonal antibodies and their role in the binding to receptors.
    Kandefer-Szerszeń M, Lundgren E.
    Arch Immunol Ther Exp (Warsz); 1992 Mar 20; 40(3-4):241-6. PubMed ID: 1284462
    [Abstract] [Full Text] [Related]

  • 20. Development of neutralizing interferon antibodies after treatment with recombinant interferon-alpha 2b in patients with malignant carcinoid tumors.
    Oberg K, Alm GV.
    J Interferon Res; 1989 Sep 20; 9 Suppl 1():S45-9. PubMed ID: 2809277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.